Blood biopsy study aims to improve cancer detection and monitoring
NCT ID NCT05089747
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is looking at special markers in the blood (called biomarkers) to learn more about how to detect, diagnose, and track solid cancers. Researchers will collect blood samples from 6,000 adults with solid cancer and analyze them alongside standard tests. The goal is to see if these blood tests can help doctors better understand cancer and make more informed treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT WITH SOLID CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Edouard Herriot / Groupement Hospitalier Centre
RECRUITINGLyon, 69003, France
-
Hôpital Lyon-Sud / Groupement Hospitalier Sud
RECRUITINGPierre-Bénite, 69495, France
-
Oncologie médicale Hôpital Lyon-Sud / Groupement Hospitalier Sud
RECRUITINGPierre-Bénite, 69495, France
-
Service de Pneumologie Aigue Spécialisée et Cancérologie Thoracique Hôpital Lyon-Sud / Groupement Hospitalier Sud
RECRUITINGPierre-Bénite, 69310, France
-
Service de Pneumologie Hôpital Croix-Rousse / Groupement Hospitalier Nord
RECRUITINGLyon, 69004, France
-
Service de Pneumologie Hôpital Louis Pradel / Groupement Hospitalier Est
RECRUITINGBron, 69500, France
-
Service de dermatologie Hôpital Lyon-Sud / Groupement Hospitalier Sud
RECRUITINGPierre-Bénite, 69495, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug shield nerves from Chemotherapy's side effects?
- Can a Tumor's DNA guide better cancer care for kids?
- Can a new PET tracer reveal a key cancer target?
- Can a smart drug home in on Hard-to-Treat cancers?
- Can a new tracer light up cancer growth?
- Can a Dual-Pronged antibody outsmart advanced cancers?